Back to search

Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.

Data up to Jan 2025

Published2002
Citations92
References47

Total Citations Per Year

Abstract

References (47)

Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c

1996 • 5,133 citations

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1991 • 4,682 citations

BCL-2 family members and the mitochondria in apoptosis

1999 • 3,657 citations

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

1993 • 3,465 citations

Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3

1997 • 3,130 citations

Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

1983 • 1,808 citations

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

1998 • 1,394 citations

Induction of Apoptosis by Cancer Chemotherapy

2000 • 1,239 citations

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1998 • 985 citations

More than one way to die: apoptosis, necrosis and reactive oxygen damage

1999 • 850 citations

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1997 • 749 citations

Oxidants in mitochondria: from physiology to diseases

1995 • 543 citations

Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

1997 • 411 citations

Molecular mechanisms involved in cisplatin cytotoxicity

2000 • 380 citations

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

1997 • 379 citations

Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.

2001 • 293 citations

Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.

2001 • 287 citations

Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family

1995 • 279 citations

Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.

1997 • 183 citations

Low-Dose Chemotherapy With Central Nervous System Prophylaxis and Zidovudine Maintenance in AIDS-Related Lymphoma

1991 • 174 citations

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.

1998 • 164 citations

Modulation of cis-diamminedichloroplatinum(II) resistance: a review

1992 • 161 citations

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy

1993 • 155 citations

Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin

1985 • 154 citations

Apoptosis: checkpoint at the mitochondrial frontier

1999 • 152 citations

Apoptosis

1999 • 140 citations

Modulation of Caspase-8 and FLICE-Inhibitory Protein Expression as a Potential Mechanism of Epstein-Barr Virus Tumorigenesis in Burkitt’s Lymphoma

1999 • 140 citations

Cisplatin resistance and oncogenes - a review

2000 • 116 citations

Nonclassical Platinum Antitumor Agents: Perspectives for Design and Development of New Drugs Complementary to Cisplatin

1993 • 113 citations

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

2000 • 104 citations

Protein translocation in apoptosis

1999 • 96 citations

Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.

1997 • 90 citations

Bcl-2 family proteins: regulators of chemoresistance in cancer

1995 • 89 citations

A carbocyanine dye, DiOC6(3), acts as a mitochondrial probe in human neutrophils

1982 • 88 citations

Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression

2000 • 74 citations

Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.

2000 • 71 citations

Modulation of NF-κB, p53 and Bcl-2 in apoptosis induced by cisplatin in HeLa cells

1997 • 66 citations

Identification of genes differentially expressed in association with acquired cisplatin resistance

2000 • 62 citations

Molecules and Mechanisms

1995 • 59 citations

Mitochondria and apoptosis: HQ or high-security prison?

1999 • 53 citations

Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry

1997 • 52 citations

A portrait of the Bcl-2 protein family: life, death, and the whole picture.

1999 • 50 citations

Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.

1996 • 37 citations

Cisplatin inhibits the expression of X-chromosome-linked inhibitor of apoptosis protein in an oral carcinoma cell line

2001 • 29 citations

Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin

1999 • 27 citations

Cisplatin resistance in cyclic AMP-dependent protein kinase mutants

1998 • 21 citations

Prognostic Factors in the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma

2002 • 13 citations

Cited By (0)

Loading...
Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis… (2002) – PubMed | Metascience Observatory Explorer